MI Biotech Consulting ApS: Financial statements 2024
CVR: 43476238
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MI Biotech Consulting ApS (CVR 43476238) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 914,266 and a net result of DKK 254,966. Equity in the 2024 report amounted to DKK 799,249. The solvency ratio was 60.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 914,266
- Profit/Loss
- DKK 254,966
- Equity
- DKK 799,249
- Total Assets
- DKK 1,317,239
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MI Biotech Consulting ApS has published its interim report for the period August 29, 2022 to December 31, 2023.
About MI Biotech Consulting ApS
MI Biotech Consulting ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2022. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jesper Mørk. The company is owned by Mørk Innovation ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 489,882 and a net result of DKK -115,163 compared with DKK 254,966 the year before. Equity in the 2025 report amounted to DKK 684,087.